171 related articles for article (PubMed ID: 17179707)
1. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus.
van Harten B; Oosterman JM; Potter van Loon BJ; Scheltens P; Weinstein HC
Eur Neurol; 2007; 57(2):70-4. PubMed ID: 17179707
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus.
van Harten B; Oosterman J; Muslimovic D; van Loon BJ; Scheltens P; Weinstein HC
Age Ageing; 2007 Mar; 36(2):164-70. PubMed ID: 17350976
[TBL] [Abstract][Full Text] [Related]
3. Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
Sink KM; Divers J; Whitlow CT; Palmer ND; Smith SC; Xu J; Hugenschmidt CE; Wagner BC; Williamson JD; Bowden DW; Maldjian JA; Freedman BI
Diabetes Care; 2015 Feb; 38(2):206-12. PubMed ID: 25205141
[TBL] [Abstract][Full Text] [Related]
4. [Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus].
Samoilova IG; Matveeva MV; Kudlay DA; Tonkikh OS; Tolmachev IV
Ter Arkh; 2021 Nov; 93(11):1349-1358. PubMed ID: 36286658
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.
Manschot SM; Biessels GJ; de Valk H; Algra A; Rutten GE; van der Grond J; Kappelle LJ;
Diabetologia; 2007 Nov; 50(11):2388-97. PubMed ID: 17764005
[TBL] [Abstract][Full Text] [Related]
6. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.
Godin O; Maillard P; Crivello F; Alpérovitch A; Mazoyer B; Tzourio C; Dufouil C
Cerebrovasc Dis; 2009; 28(2):177-84. PubMed ID: 19556771
[TBL] [Abstract][Full Text] [Related]
7. The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients.
Anan F; Masaki T; Iwao T; Eto T; Shimomura T; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H
Curr Med Res Opin; 2008 Jun; 24(6):1561-7. PubMed ID: 18423105
[TBL] [Abstract][Full Text] [Related]
8. Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people.
Murray AD; Staff RT; Shenkin SD; Deary IJ; Starr JM; Whalley LJ
Radiology; 2005 Oct; 237(1):251-7. PubMed ID: 16126931
[TBL] [Abstract][Full Text] [Related]
9. Cerebral perfusion and aortic stiffness are independent predictors of white matter brain atrophy in type 1 diabetic patients assessed with magnetic resonance imaging.
van Elderen SG; Brandts A; van der Grond J; Westenberg JJ; Kroft LJ; van Buchem MA; Smit JW; de Roos A
Diabetes Care; 2011 Feb; 34(2):459-63. PubMed ID: 21216862
[TBL] [Abstract][Full Text] [Related]
10. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.
Appelman AP; Vincken KL; van der Graaf Y; Vlek AL; Witkamp TD; Mali WP; Geerlings MI;
Cerebrovasc Dis; 2010; 29(1):28-35. PubMed ID: 19893309
[TBL] [Abstract][Full Text] [Related]
11. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
[TBL] [Abstract][Full Text] [Related]
12. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
[TBL] [Abstract][Full Text] [Related]
13. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
Jokinen H; Lipsanen J; Schmidt R; Fazekas F; Gouw AA; van der Flier WM; Barkhof F; Madureira S; Verdelho A; Ferro JM; Wallin A; Pantoni L; Inzitari D; Erkinjuntti T;
Neurology; 2012 May; 78(22):1785-92. PubMed ID: 22592361
[TBL] [Abstract][Full Text] [Related]
14. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
15. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
[TBL] [Abstract][Full Text] [Related]
16. Multi-scale glycemic variability: a link to gray matter atrophy and cognitive decline in type 2 diabetes.
Cui X; Abduljalil A; Manor BD; Peng CK; Novak V
PLoS One; 2014; 9(1):e86284. PubMed ID: 24475100
[TBL] [Abstract][Full Text] [Related]
17. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).
Akisaki T; Sakurai T; Takata T; Umegaki H; Araki A; Mizuno S; Tanaka S; Ohashi Y; Iguchi A; Yokono K; Ito H
Diabetes Metab Res Rev; 2006; 22(5):376-84. PubMed ID: 16506272
[TBL] [Abstract][Full Text] [Related]
18. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
[TBL] [Abstract][Full Text] [Related]
19. White matter lesions as a feature of cognitive impairment, low vitality and other symptoms of geriatric syndrome in the elderly.
Sonohara K; Kozaki K; Akishita M; Nagai K; Hasegawa H; Kuzuya M; Yokote K; Toba K
Geriatr Gerontol Int; 2008 Jun; 8(2):93-100. PubMed ID: 18713161
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinaemia is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients.
Shimomura T; Anan F; Umeno Y; Eshima N; Saikawa T; Yoshimatsu H; Fujiki M; Kobayashi H
Eur J Neurol; 2008 Mar; 15(3):289-94. PubMed ID: 18290850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
